- Open access
- Published:
Effector cell mediated cytotoxicity measured by intracellular Granzyme B release in HIV infected subjects
Biological Procedures Online volume 5, pages 182–188 (2003)
Abstract
CD8+ cytotoxic T lymphocyte (CTL) activity is currently believed to be one of the key immunologic mechanisms responsible for the prevention or attenuation of HIV-1 infection. The induction of CD8+ T cell activation may also result in the production of soluble or non-classical lytic factors that are associated with protection from infection or slower disease progression. Traditionally, CD8+ CTL responses have been measured by the classic chromium release assay, monitoring the ability of T cells (Effector cells) to lyse radiolabelled HLA — matched “target cells“ that express the appropriate antigen-MHC complex. This method is not only labor intensive, semi quantitative assay at best, but also needs fresh, non-cryopreserved cells. Recently, cytokine specific ELISPOT assays or tetrameric MHC-I/ peptide complexes have utilized to directly quantitate circulating CD8+ effector cells, and these assays are more sensitive, quantitative and reproducible than the traditional CTL lysis assay and can also be performed on cryopreserved cells. Although these are reproducible assays for the assessment of soluble antiviral activity secreted by activated T cell populations they can be extremely expensive to perform. We have used FACS Analysis to measure Granzyme B release as a function of cell mediated cytotoxicity. This method helps quantitate the CTL activity and also identifies the phenotype of the cells elucidating this immune response. The method described not only monitors immunological response but also is also simple to perform, precise and extremely time efficient and is ideal for screening a large number of samples.
Abbreviations
- CTL:
-
cytotoxic T lymphocyte
- HIV:
-
Human Immunodeficiency Virus
- NK:
-
natural killer
- PI:
-
propidium iodide
- 7AAD:
-
7-aminoactinomycin D
- PBMCs:
-
peripheral blood mononuclear cells
- E:T:
-
Effector: Target
- R1 / R2:
-
Region 1/Region 2
- FL-1:
-
fluorescence axis 1
- FL-2:
-
fluorescence axis 2
- SSC:
-
side scatter
- PE:
-
phycoerythrin
References
Walker BD, Chakrabarti S, Moss B, Paradis TJ, Flynn T, Durno AG, Blumberg RS, Kaplan JC, Hirsch MS, Schooley RT. HIV-specific cytotoxic T lymphocytes in seropositive individuals.Nature 1987; 328:345–348.
Mackewicz CE, Yang LC, Lifson JD, Levy JA. Non-cytolytic CD8 T-cell anti-HIV responses in primary HIV-1 infection.Lancet 1994; 344:1671–1673.
Scheibenbogen C, Romero P, Rivoltini L, Herr W, Schmittel A, Cerottini JC, Woelfel T, Eggermont AM. Quantitation of antigen reactive T cells in peripheral blood by IFN gamma - ELISPOT assay and Chromium - release assay: a four center comparative trial.J Immunol Methods 2000; 244(1–2):81–89.
Rininsland FH, Helms T, Asaad RJ, Boehm BO, Tary-Lehmann M. Granzyme B ELISPOT assay for ex vivo measurements of T cell Immunity.J Immunol Methods 2000; 240(1–2):143–155.
Murali-Krishna K, Altman JD, Suresh M, Sourdive D, Zajac A, Ahmed R. In vivo dynamics of anti-viral CD8 T cell responses to different epitopes. An evaluation of bystander activation in primary and secondary responses to viral infection.Adv Exp Med Biol 1998; 452:123–142.
Altman JD, Moss PA, Goulder PJ, Barouch DH, McHeyzer-Williams MG, Bell JI, McMichael AJ, Davis MM. Phenotypic analysis of antigen-specific T lymphocytes.Science 1996; 274(5284):94–96.
Goepfert PA, Bansal A, Edwards BH, Ritter GD Jr, Tellez I, McPherson SA, Sabbaj S, Mulligan MJ. A significant number of human immunodeficiency virus epitope- specific cytotoxic T lymphocytes detected by tetramer binding do not produce gamma interferon.J Virol 2000; 74(21):10249–10255.
Kummer JA, Kamp AM, Tadema TM, Vos W, Meijer CJ, Hack CE. Localization and identification of granzymes A and B-expressing cells in normal human lymphoid tissue and peripheral blood.Clin Exp Immunol 1995; 100(1):164–172.
Derby E, Reddy V, Baseler M, Malyguine A. Flow cytometric assay for the simultaneous Analysis of cell mediated cytotoxicity and effector cell phenotype.Biotechniques 2001; 31:660–665.
Kroemer G. The pharmacology of T cell apoptosis.Adv Immunol 1995; 58:211–296.
Koopman G, Reutelingsperger CP, Kuijten GA, Keehnen RM, Pals ST, van Oers MH. Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis.Blood 1994; 84(5):1415–1420.
Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger C. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V.Immunol Methods 1995; 184(1):39–51.
Author information
Authors and Affiliations
Corresponding author
Additional information
Published: September 5, 2003
Rights and permissions
About this article
Cite this article
Mahajan, S.D., Aalinkeel, R., Schwartz, S.A. et al. Effector cell mediated cytotoxicity measured by intracellular Granzyme B release in HIV infected subjects. Biol. Proced. Online 5, 182–188 (2003). https://doi.org/10.1251/bpo60
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1251/bpo60